Resmed’s 20-Year CFO Brett Sandercock Announces Retirement

Resmed announced that chief financial officer (CFO) Brett Sandercock plans to retire effective May 4, 2026. After conducting a comprehensive search, Aaron Bloomer was named as his successor.

“After 27 years with Resmed, including 20 as CFO, Brett leaves an outstanding legacy of disciplined leadership and trusted partnership,” said Mick Farrell, chairman and CEO of Resmed. “Brett’s leadership has helped guide Resmed through significant growth and transformation, while keeping a clear focus on long-term value creation and our goal to improve more than 500 million lives. On behalf of the Board and the entire Resmed team, I thank Brett for his exceptional contributions and wish him all the best in his well-earned retirement.”

Bloomer joins Resmed from Exact Sciences, a cancer diagnostics company that was recently acquired by Abbott. He was CFO there, as well.

He brings over 17 years of global finance and operating leadership experience. At Exact Sciences, Bloomer helped shape and executive a new strategic plan that delivered strong revenue growth, significant margin expansion and substantial increases in free cash flow.

Bloomer previously had senior finance leadership positions at Baxter and 3M. During his over a decade-long tenure at 3M, he served in many roles including senior VP of financial planning and analysis, as a regional CFO based in China, and a global divisional CFO based in Japan.

“Aaron is a proven financial leader with deep experience driving operational discipline, strategic growth and global financial performance. He stood out as a star during the selection process with his intelligence and experience in growth businesses,” Farrell said. “We look forward to the leadership and broad perspective Aaron will bring as we continue to execute on our 2030 strategy, scale our business and drive sustainable long-term growth.”

“I’m honored to join Resmed at such an exciting time in its journey,” said Aaron Bloomer. “Resmed’s leadership in digital health and its vision to create a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home, resonates with me. I look forward to working with the team to build on its strong foundation and support continued growth and value creation.”

Brett Sandercock will serve as an advisor to the CEO through the end of calendar year 2027.